Showing results (421-430 of 1,523) with videos related to

Sort By:
Pageof 153
CPT: Pharmacometrics & Systems Pharmacology|February 17, 2026
Model-Based Meta-Analysis of Overall Survival in Vulnerable Platinum-Ineligible NSCLC PopulationsJoseph Chen, Russ Wada, Nancy Zhang, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 2, 2026
Population Pharmacokinetic/Pharmacodynamic Modeling of Donidalorsen, an Antisense Oligonucleotide in Development for Prophylaxis of Hereditary AngioedemaJohn K Diep, Miao Liu, Pratap Singh, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 23, 2026
Latent Variable Indirect Response Modeling of Cendakimab Exposure-Response for Longitudinal Dysphagia Days Using a Combined Uniform-Binomial Likelihood FrameworkShengnan Du, Jessica Wojciechowski, Peijin Zhang, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 19, 2026
Tutorial on Causal Mediation Analysis for PharmacometriciansSebastiaan Camiel Goulooze, Eleonora Marostica, Nelleke Snelder
CPT: Pharmacometrics & Systems Pharmacology|January 16, 2026
Development of a Physiologically Based Model of Bilirubin Metabolism in Health and Disease and Its Comparison With Real-World DataAhenk Zeynep Sayin, Lars Kuepfer
CPT: Pharmacometrics & Systems Pharmacology|March 15, 2025
Translational Physiologically Based Pharmacokinetic Modeling to Predict Human Pulmonary Kinetics After Lung DeliveryHaini Wen, Muhammad Waqas Sadiq, Lena E Friberg, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 17, 2025
Comparison of Model-Predicted and Observed Evinacumab Pharmacokinetics and Efficacy in Children Aged < 5 Years With Homozygous Familial HypercholesterolemiaSébastien Bihorel, Robert Dingman, Jeanne Mendell, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
Multiscale kinetic modeling of liposomal Doxorubicin delivery quantifies the role of tumor and drug-specific parameters in local delivery to tumorsB S Hendriks, J G Reynolds, S G Klinz, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
Pharmacokinetic-pharmacodynamic modeling of severity levels of extrapyramidal side effects with markov elementsV Pilla Reddy, K J Petersson, A A Suleiman, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
A PBPK Model to Predict Disposition of CYP3A-Metabolized Drugs in Pregnant Women: Verification and Discerning the Site of CYP3A InductionA B Ke, S C Nallani, P Zhao, et al.
Pageof 153